Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics

Filardo, Giuseppe; Madry, Henning; Jelic, Mislav; Roffi, Alice; Cucchiarini, Magali; Kon, Elizaveta
August 2013
Knee Surgery, Sports Traumatology, Arthroscopy;Aug2013, Vol. 21 Issue 8, p1717
Academic Journal
Purpose: The aim of this systematic review is to examine the available clinical evidence in the literature to support mesenchymal stem cell (MSC) treatment strategies in orthopaedics for cartilage defect regeneration. Methods: The research was performed on the PubMed database considering the English literature from 2002 and using the following key words: cartilage, cartilage repair, mesenchymal stem cells, MSCs, bone marrow concentrate (BMC), bone marrow-derived mesenchymal stem cells, bone marrow stromal cells, adipose-derived mesenchymal stem cells, and synovial-derived mesenchymal stem cells. Results: The systematic research showed an increasing number of published studies on this topic over time and identified 72 preclinical papers and 18 clinical trials. Among the 18 clinical trials identified focusing on cartilage regeneration, none were randomized, five were comparative, six were case series, and seven were case reports; two concerned the use of adipose-derived MSCs, five the use of BMC, and 11 the use of bone marrow-derived MSCs, with preliminary interesting findings ranging from focal chondral defects to articular osteoarthritis degeneration. Conclusions: Despite the growing interest in this biological approach for cartilage regeneration, knowledge on this topic is still preliminary, as shown by the prevalence of preclinical studies and the presence of low-quality clinical studies. Many aspects have to be optimized, and randomized controlled trials are needed to support the potential of this biological treatment for cartilage repair and to evaluate advantages and disadvantages with respect to the available treatments. Level of evidence: IV.


Related Articles

  • Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials. Philippe, Bourin; Luc, Sensebé; Valérie, Planat-Bénard; Jérome, Roncalli; Alessandra, Bura-Rivière; Louis, Casteilla // Stem Cells International;2010, p1 

    Present in numerous tissues, mesenchymal stem cells/multipotent stromal cells (MSCs) can differentiate into different cell types from a mesoderm origin. Their potential has been extended to pluripotency, by their possibility of differentiating into tissues and cells of nonmesodermic origin....

  • Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis. Waterman, Ruth S.; Henkle, Sarah L.; Betancourt, Aline M.; Fiorina, Paolo // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: Currently, there are many promising clinical trials using mesenchymal stem cells (MSCs) in cell-based therapies of numerous diseases. Increasingly, however, there is a concern over the use of MSCs because they home to tumors and can support tumor growth and metastasis. For instance,...

  • In vitro gene and chromosome characterization of expanded bone marrow mesenchymal stem cells for musculo-skeletal applications. ROSETI, L.; SERRA, M.; CANELLA, E.; MUNNO, C.; TOSI, A.; ZUNTINI, M.; PANDOLFI, M.; SANGIORGI, L.; BISO, R.; PITTALIS, M. C.; BINI, C.; PELOTTI, S.; GASBARRINI, A.; BORIANI, L.; BASSI, A.; GRIGOLO, B. // European Review for Medical & Pharmacological Sciences;Dec2014, Vol. 18 Issue 23, p3702 

    OBJECTIVE: A number of studies have shown the role of expanded Bone Marrow-derived Mesenchymal Stem Cells in the repair and regeneration of musculo-skeletal tissues. The current European regulations define in vitro expanded cells for clinical purposes as substantially manipulated and include...

  • CORRECTION: Proliferation and multi-differentiation potentials of human mesenchymal stem cells on thermoresponsive PDMS surfaces grafted with PNIPAAm. Dongyan SHI; Dan MA; Feiqing DONG; Chen ZONG; Liyue LIU; Dan SHEN; Wenji YUAN; Xiangmin TONG; Hengwu CHEN; Jinfu WANG // Bioscience Reports;Dec2010, Vol. 30 Issue 6, p455 

    A correction to the article "Proliferation and multi-differentiation potentials of human mesenchymal stem cells on thermoresponsive PDMS surfaces grafted with PNIPAAm," by Dongyan Shi and colleagues in the 30th volume of the "Bioscience Reports" journal is presented.

  • Erratum.  // Cellular Physiology & Biochemistry (Karger AG);Oct2017, Vol. 42 Issue 3, p1275 

    A correction to the article "MiR-495 Promotes Senescence of Mesenchymal Stem Cells by Targeting Bmi-1," by Lin et al, that was published in a 2017 issue is presented.

  • Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials. Jung Hwa Seo; Sung.-Rae Cho // Yonsei Medical Journal;Nov2012, Vol. 53 Issue 6, p1059 

    Stem cells are emerging as therapeutic candidates in a variety of diseases because of their multipotent capacities. Among these, mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord blood or adipose tissue, comprise a population of cells that exhibit extensive proliferative...

  • Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use. Mareschi, Katia; Rustichelli, Deborah; Calabrese, Roberto; Gunetti, Monica; Sanavio, Fiorella; Castiglia, Sara; Risso, Alessandra; Ferrero, Ivana; Tarella, Corrado; Fagioli, Franca // Stem Cells International;2012, p1 

    Mesenchymal stem cells (MSCs) are a promising source for cell therapy due to their pluripotency and immunomodulant proprieties. As the identification of "optimal" conditions is important to identify a standard procedure for clinical use. Percoll, Ficoll and whole bone marrow directly plated were...

  • Risk of genetic transformation of multipotent mesenchymal stromal cells in vitro. Nikitina, V.; Chausheva, A. // Russian Journal of Genetics;Jan2014, Vol. 50 Issue 1, p91 

    Proof of the efficacy of cell therapy by numerous studies and clinical trials inevitably has raised the question of improving the regulatory framework that governs its use. Particular attention should be paid to the genetic safety of cell preparations. The immune, genetic, and pharmacological...

  • Clinical Application ofMesenchymal StemCells in the Treatment and Prevention of Graft-versus-Host Disease. Yi Lin; Hogan, William J. // Advances in Hematology;2011, Vol. 2011, p1 

    Mesenchymal stem cells (MSCs) represent a heterogeneous population of stromal cells with pluripotent mesenchymal differentiation potential. They have been found to have immunosuppressive properties and the ability to modulate angiogenesis and endogenous tissue repair by in vitro and animal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics